Plain-English translation of NCT07004673 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing two advanced imaging techniques—18F FDG and 68Ga FAPI PET/MR—to better understand which fatty plaques in your carotid arteries (the blood vessels in your neck) are most likely to rupture and cause a stroke. Right now, doctors can see the shape and size of these plaques, but these new scans may help identify which ones are unstable and need urgent treatment. The goal is to catch dangerous plaques early so you can prevent a stroke before it happens.
Fatty plaque buildup in carotid arteries is a major cause of stroke, but doctors currently struggle to tell which plaques are truly dangerous. This trial exists to develop better imaging tools that can spot the most vulnerable plaques by detecting inflammation and scar tissue—signs that a plaque is at risk of breaking apart.
You likely qualify if…
You likely don't qualify if…
You will undergo advanced imaging scans—a combination PET/MR scan that takes pictures of your carotid arteries to look at plaque composition and inflammation. Depending on your doctor's recommendation and local guidelines, you may also receive standard medical care, medication, or other procedures (like carotid stenting or surgery) to manage your condition. The study involves about 100 patients total, and the imaging visit is the primary research component.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China